Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
The Dow Jones uses price weighting, which gives more influence to higher-priced stocks. This note covers the rationale and implications for investors.
25,369 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
As markets shift in 2026, four high-yield passive income plays are drawing risk-savvy investors seeking cash flow and...
Adobe is navigating a fast-changing software landscape in 2026. This guide breaks down the 2026 earnings outlook, key...
The White House-backed gala for TRUMP holders comes as the meme coin rebounds strongly following a trough, pushing th...
Bitcoin flirted with $76,000 as long-dormant coins linger. The Coin Days Destroyed Multiple hit a 2022-era low, fueli...
When a luxury carmaker unveils something truly polarizing, investors sit up. This piece breaks down what ferrari laun...
Get ahead of ARBE's Q1 2026 results with a practical framework. This guide breaks down what to watch in arbe (arbe) 2...
Investors debating IHE vs XBI face a trade-off between stability and growth. This guide breaks down how ishares pharm...
SpaceX shares declined about 7% after the Federal Reserve kept rates steady, ending a brief three-day rally since its...
Two consumer stars with very different paths battle for investors' attention. One mixes health-forward fast-casual ex...
A dividend-focused ETF beats a broad market gain on yield and stability. Invesco’s SPHD offers 4.57% income with lowe...
As 2026 unfolds, Caesars Entertainment and Six Flags chart different courses in the leisure market. This guide breaks...